Skip to main content
Caplight Logo









Bellen Chemistry

Bellen Chemistry

Private
BeijingHealthcare & Life Scienceshttps://bellenchem.com/

Last Round

Series D

Extension

Aug 19, 2020

Est. Valuation

$360.2M

Total Funding Raised

$75.5M

Company Overview

Bellen Chemistry is a pharmaceutical and biotechnology company that provides integrated contract research, development, and manufacturing services for small molecule drug discovery and commercialization.

Sector

Healthcare & Life Sciences

Verticals

Biotechnology, Drug Discovery, Pharma Supply Chain, Clinical Trials

Business Model

B2B

Customer Profile

Services & Consulting, Data as a Service

AI Layer

Application

Keywords

contract research organizationCROcontract development and manufacturing organizationCDMOsmall molecule chemistryAPI manufacturingmedicinal chemistrycustom synthesisheterocyclic building blockspharma outsourcingprocess R&DPROTAC chemistryflow chemistrydrug development partnerbiocatalysisdrug discovery services

Historical Pricing

Historical view of private secondary pricing and transaction trends.

Unlock Pricing Charts

Sign up to view complete historical pricing and secondary transactions.

Caplight Momentum Score

Proprietary index based on bid/ask volume and sentiment.

View Momentum History

Track how buyer interest and sentiment changes over time.

Bellen Chemistry Comparables

Compare Bellen Chemistry with similar companies based on industry and business-model similarity.

Bellen Chemistry comparables — related companies by embedding similarity
CompanySimilarityMarket Cap
Sai Life Sciences
86%
WuXi AppTec
83%
BioDuro-Sundia
83%

Bellen Chemistry Funding Rounds

Historical fundraising activity

Data table
RoundDateAmount RaisedValuationInvestorsSources
Series D ExtensionAug 19, 2020
Series DJun 30, 2020
Series CSep 27, 2018
Series BSep 22, 2017
Series AJul 1, 2016

Bellen Chemistry Investors

Notable investors and investment history

Bellen Chemistry investors
InvestorRounds
HighLight CapitalSeries D Extension
Boxin CapitalSeries D, Series A
Gopher Asset ManagementSeries B
招银国际金融有限公司Series C
Legend CapitalSeries D, Series C, Series B
Shenzhen Dachen Caizhi Venture Capital ManagementSeries B
CICC CapitalSeries D, Series B, Series C

Market signals

Structured signals derived from secondary market and firmographic data.

  • May 1, 2025

    Monthly visitors increased 51% MoM, reaching 1.4K.

  • Mar 17, 2025

    Monthly visitors increased 64% MoM.

Bellen Chemistry Filings

SEC and related filings with document metadata.

Data table
TypedDateAmount OfferedAmount SoldFillingPagesDownload
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation

Bellen Chemistry Filings

SEC and related filings with document metadata.

Frequently Asked Questions

Common questions about Bellen Chemistry's valuation, stock price, and market status.

Firmographic Details

HeadquartersBeijing
Employee Range14
Year Founded2007
Last FundingAug 19, 2020

Institutional Data Access

Join leading institutional investors using Caplight to access private market data, discover pricing, and execute secondary block trades.

Requires verified institutional or accredited status.

See something wrong or outdated?